Current Trends in the Management of Gastroesophageal Reflux Disease : A Review

Abstract EN

Gastroesophageal reflux disease (GERD) is a chronic disorder of the upper gastrointestinal tract with global distribution.

The incidence is on the increase in different parts of the world.

In the last 30 to 40 years, research findings have given rise to a more robust understanding of its pathophysiology, clinical presentation, and management.

The current definition of GERD (The Montreal definition, 2006) is not only symptom-based and patient-driven, but also encompasses esophageal and extraesophageal manifestations of the disease.

The implication is that the disease can be confidently diagnosed based on symptoms alone.

Nonerosive reflux disease (NERD) remains the predominant form of GERD.

Current thinking is that NERD and erosive reflux disease (ERD) are distinct phenotypes of GERD rather than the old concept which regarded them as components of a disease spectrum.

Non erosive reflux disease is a very heterogeneous group with significant overlap with other functional gastrointestinal disorders.

There is no gold standard for the diagnosis of GERD.

Esophageal pH monitoring and intraluminal impedance monitoring have thrown some light on the heterogeneity of NERD.

A substantial proportion of GERD patients continue to have symptoms despite optimal PPI therapy, and this has necessitated research into the development of new drugs.

Several safety concerns have been raised about chronic use of proton pump inhibitors but these are yet to be substantiated in controlled studies.

The debate about efficacy of long-term medical treatment compared to surgery continues, however, recent data indicate that modern surgical techniques and long-term PPI therapy have comparable efficacy.

These and other issues are subjects of further research.